Data Foundry

Drug recalls 2015

KETOROLAC Tromethamine Inj — Class II drug recall D-1242-2015

Ongoing recall by Hospira Inc., reported 2015-07-22, distributed nationwide. Crystallization; identified as calcium salt of Ketorolac

Recall numberD-1242-2015
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., Lake Forest, IL, United States
Recall initiated2015-06-30
Classified2015-07-15
Reported by FDA2015-07-22
DistributedNationwide (US)
Countries outside the USCA, SG
NDC00409-3793, 00409-3793-01, 00409-3793-19, 00409-3793-25, 00409-3795, 00409-3795-01, 00409-3795-19, 00409-3795-25, 00409-3796, 00409-3796-01, 00409-3796-19, 00409-3796-25, 00409-3796-49
Lot numbers31074DK
Expiration dates2015-07-01, 2015-08-01, 2015-09-01, 2015-10-01, 2016-01-01, 2016-05-01, 2016-10-01

Product

KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49

Reason for recall

Crystallization; identified as calcium salt of Ketorolac

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1242-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.